Back
Vertex Pharmaceuticals Stock Predictions
Sponsored
VRTX
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
49
VRTX
Vertex Pharmaceuticals
Last Price:
$407.63
Seasonality Move:
2.63%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Vertex Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 27.5% based on the past 33 years of stock performance.
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Vertex Pharmaceuticals Stock Undervalued?The current Vertex Pharmaceuticals [VRTX] share price is $408.18. The Score for VRTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 27.5% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Sell
49
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals overpriced?
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
519.88
52-Week Low:
377.85
Prediction Charts
Market Cap:
105.1B
Price in USD:
408.18
Volume:
1.5M
Beta:
0.95
Technical Analysis
SMA50:
467.45
SMA100:
470.45
SMA200:
457.15
52-Wk Change:
0.72%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?Yes, Vertex Pharmaceuticals is a publicly traded company.
-
What is the Vertex Pharmaceuticals stock quote today?The Vertex Pharmaceuticals stock price is 408.18 USD today.
-
How to buy Vertex Pharmaceuticals stock online?You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 461.35 | 459.92 | 467.06 | 457.96 |
Dec-6 | 458.06 | 462.10 | 465.91 | 456.86 |
Dec-9 | 467.33 | 473.98 | 476.02 | 467.00 |
Dec-10 | 473.30 | 469.22 | 476.46 | 465.12 |
Dec-11 | 472.31 | 468.29 | 472.33 | 460.74 |
Dec-12 | 466.52 | 464.12 | 470.25 | 460.05 |
Dec-13 | 462.33 | 463.73 | 466.71 | 459.79 |
Dec-16 | 463.37 | 468.09 | 470.08 | 462.13 |
Dec-17 | 468.07 | 469.24 | 474.19 | 465.62 |
Dec-18 | 467.06 | 447.50 | 471.05 | 445.87 |
Dec-19 | 391.00 | 396.64 | 404.04 | 377.85 |
Dec-20 | 395.72 | 397.27 | 401.31 | 386.49 |
Dec-23 | 391.87 | 405.27 | 405.93 | 390.92 |
Dec-24 | 401.53 | 408.18 | 410.68 | 401.27 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.56 per share, and an increase next year of $18.20 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.